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Abstract
Background: Chikungunya (CHIK) fever is a viral disease transmitted to humans by the bite of
Chikungunya virus (CHIK virus) infected Aedes  mosquitoes. CHIK virus is a member of the
Alphavirus genus of the family Togaviridae. Previous reports have indicated that infection with CHIK
virus produces an acute arthritis in human hosts by large area of necrosis and collagenosis or
fibrosis.
Results: We carried out the present study to determine the effect of chikungunya on the collagen
and connective tissue metabolism in 75 chikungunya-affected people. First, we screened for
mucopolysaccharides in urine by Cetyl Trimethyl Ammonium Bromide (CTAB) test. Appearance
of heavy precipitate indicates the presence of higher levels of mucopolysaccharides and later
quantified by DMB dye method. The urinary mucopolysaccharide in CHIK patients was 342 ± 45
mg/l compared to healthy controls (45 ± 5.6 mg/l). The collagen building blocks, proline and
hydroxyproline were also measured in CHIK patients and observed higher excretion compared to
healthy controls. Urinary excretions hydroxyproline was greater than the proline levels.
Conclusion: These results indicate that CHIK virus infection affects and damage the cartilage and
connective metabolism and releases the degraded products from the tissue and responsible for
increasing the levels of proline, hydroxyproline and mucopolysaccharides in CHIK affected patients.
Background
Chikungunya (CHIK) fever is a viral disease transmitted
to humans by the bite of Chikungunya virus (CHIK virus)
infected Aedes mosquitoes. CHIK virus is a member of the
Alphavirus genus of the family Togaviridae. CHIK virus was
first isolated from the serum of a febrile patient during a
dengue epidemic that occurred in the Newala District,
Tanzania in 1953 [1]. The Alphaviruses are enveloped par-
ticles and their genome consists of a single-stranded, pos-
itive-sense RNA molecule of approximately 12000
nucleotides. CHIK virus is an important human pathogen
that causes a disease syndrome characterized by fever,
headache, rash, nausea, vomiting, myalgia and arthralgia
[2-8]. Its association with a fatal haemorrhagic condition
was reported in India [9]. CHIK virus is geographically
distributed from Africa through Southeast Asia, and its
transmission to humans is mainly through Aedes species
mosquitoes [1]. Since 1953, CHIK viurs has caused
numerous well-documented outbreaks and epidemics in
both Africa and Southeast Asia, involving hundreds of
thousands of people [10-12]. Recent reports have
described a massive outbreak of CHIK disease occurring
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on islands in the Indian Ocean, off the east coast of Africa
[5,8,13]. Reemergence of CHIK has also been reported
from Indonesia [14] and very recent massive outbreak in
India. No treatment or vaccine is available, and relatively
little research has been conducted into its pathogenesis,
compared with that of other Arboviruses, such as dengue.
Previous reports have indicated that infection with CHIK
virus produces an acute arthritis in human hosts [7,15,16]
by large area of necrosis and collagenosis or fibrosis [17].
Arthritis is the inflammation of a joint and its surround-
ing tissues, including the cartilage, ligaments, and ten-
dons. Connective tissue is mainly composed of
mucopolysaccharides, protein substances – collagen with
major amino acids proline, hydroxyproline etc, calcium,
sulfur, and collagen. Mucopolysaccharide, proline and
hydroxyproline measurements in urine are used in the
diagnosis and treatment of various inheritable disorders
that affect bone and connective tissues. Their presence in
urine is originated from ground substance of collagen,
and bone [18-20]. Though many reports state that CHIK
virus produces arthritis in humans. The biochemical
mechanisms and the changes of mucopolysaccharides,
proline and hydroxyproline in this acute joint pain have
not been reported in past literature. During last year mon-
soon outbreak of CHIK fever in Southern parts of India
has led us to carryout the experiments on the effect of
CHIK virus on the collagen and connective tissue. In this
study we collected the blood and urine samples from
chronic CHIK fever patients and studied biochemical
parameters related to connective tissue, which is responsi-
ble for acute joint pains and arthritis.
Results
CHIK patients have reported incapacitating joint pain, or
arthritis, which may last for weeks or months. The general
biochemical parameters of CHIK patients and healthy
controls were depicted in Table 1. Serum albumin and cre-
atinine were showing significant variation with controls.
We carried out the present study to determine the effect of
CHIK on collagen and connective tissue metabolism by
measuring the levels of mucopolysaccharide, hydroxypro-
line and proline in urine samples of CHIK patients. Urine
from 75 different patients suffering with CHIK was evalu-
ated for the presence of mucopolysaccharides by screen-
ing cetyl trimethyl ammonium bromide (CTAB) test in
urine. Appearance of heavy precipitate indicates the pres-
ence of mucopolysaccharides in the sample. The amount
of precipitate depends on the concentration of mucopol-
ysaccharides. Depending upon their concentration, sam-
ples were classified as negative, mild, moderate, and
severe. In this study, we observed moderate to severe
cases. The healthy controls showed no precipitate with
CTAB. We also measured quantitatively urinary mucopol-
ysaccharides levels in the first morning urine specimens
by the simple and rapid DMB method and used in under-
standing the pathophysiology of arthritis in CHIK dis-
eases. Urinary mucopolysaccharides (GAG) excretion in
patients increased significantly compared to healthy con-
trols. We also observed the significant variation in the lev-
els of urinary excretions of hydroxyproline and proline
with healthy controls (Table 2). The patients suffering
with CHIK excreted higher levels of hydroxylproline than
proline. We also carried out the follow up study for 10
patients with their consent up to one week who has
chronic arthritic pains. The urinary excreted mucopolysac-
charides are continuously high in the first two days and
the levels were slowly decreasing on later days, but at the
end of one week (up to 10 days) we found still the
patients are excreting higher values compare to control
(Table 3). The changes in the levels of urinary hydroxypro-
line and proline were also measured and observed the sig-
nificant difference with healthy controls.
Discussion
Proteoglycan, a mucopolysaccharide building block of
cartilage within the joint space, is used by chondrocytes
(cartilage-building cells) to create more cartilage. Follow-
ing pathogenic infection, joints typically exhibit a natural
inflammatory response that mainly affects the synovium
(synovitis). This process is necessary for the innate repair
of damaged tissues, allowing the joint to recoup normal
function. Inflammatory mediators released into the joint
from such sources as nerves, immunocytes, synoviocytes,
Table 2: Effect of chikungunya (on average day 3 – 5) on the 
levels of proline, hydroxyproline and acid mucopolysaccharides
Sl No. Parameter Control Chikungunya
1. Proline 1.4 ± 0.18 mg/l 22 ± 3.2 mg/l$
2. Hydroxyproline 25 ± 1.8 mg/l 210 ± 34 mg/l$
3. Mucopolysaccharides 45 ± 5.8 mg/l 342 ± 45 mg/l$
Results are expressed as mean ± SD. $ p < 0.05 against the control 
values
Table 1: Biochemical characteristics of normal and Chikungunya 
patients
S. No Clinical data Normal Chikungunya
1. Number 20
F – 6, M – 14
75
F – 30, M – 45
2. Age (years) 20 – 50 15 – 60
3. Blood glucose 80 ± 12 mg/dl 90 ± 16 mg/dl
4. Serum total protein 7.15 ± 0.96 g/dl 6.96 ± 0.6 g/dl
5. Serum albumin 4.04 ± 0.45 g/dl 3.60 ± 0.24 g/dl$
6. A:G ratio 1 – 2 0.96 ± 0.4
7. Blood urea 36 ± 8 mg/dl 41 ± 10 mg/dl
8. Serum creatinine 0.96 ± 0.23 mg/dl 1.22 ± 0.12 mg/dl$
F-Female, M-Male, mg- milli gram, dl- deci litre.
Results are expressed as mean ± SD. $ p < 0.05 against the control 
valuesVirology Journal 2008, 5:31 http://www.virologyj.com/content/5/1/31
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and vascular endothelium help to orchestrate these heal-
ing responses. These same inflammatory mediators also
act on joint sensory nerves, leading to either excitation or
sensitization [21]. When people suffer from arthritis, they
experience a selective destruction of collagen within the
cartilage of their joints. Collagen is the most abundant
structural protein in cartilage. It helps provide elasticity of
joints and works as the "glue" that holds together the var-
ious components of cartilage. It also contains the majority
of mucopolysaccharides that give cartilage its healing
powers. Mucopolysaccharides are large-molecular mass
linear carbohydrate polymers composed of glucuronic or
iduronic acid and N-acetylglycosamine or N-acetylgalac-
tosamine units. Chondroitin sulfate and heparan sulfate
are derived from proteoglycans in which these gly-
cosaminoglycans (GAG) are covalently linked at the
reducing end to the hydroxyl group of serine residues
[22]. Proteoglycans containing GAG bound to hyaluronic
acid form large aggregates that are enmeshed in a collagen
network as the principal structural constituents of carti-
lage. Loss of proteoglycans is an early feature of matrix
resorption. The erosion of the cartilage lining the joints is
a hallmark of osteoarthritis. A corresponding increase in
GAGs has been reported in synovial fluid, serum, and
urine of patients with rheumatic arthritic diseases [23,24].
Consistent with this, we observed in our studies higher
excretion of mucopolysaccharides through urine (Table
2).
Measurement of urinary hydroxyproline excretion is used
to estimate collagen catabolism. Degradation of bone col-
lagen releases free 4-hydroxyproline and peptides con-
taining 4-hydroxyproline into the plasma. Urinary
hydroxyproline measurement is particularly useful in
monitoring treatment and progress in metabolic bone dis-
eases such as osteomalacia and osteoporosis and Paget's
disease. Hydroxyprolme appears in urine after degrada-
tion of collagen (collagenosis), which may originate from
various tissues [25]. Measuring urinary hydroxyproline
has predominantly been used to indicate bone collagen
turnover in normal and pathological conditions. Colla-
gen, which constitutes >90% of the fat-free organic matrix
of bone, is important in its structural integrity and is the
central element of connective tissue structure in which the
mineral phase crystallizes during bone formation [20,26].
Urinary hydroxyproline reflects daily collagen turnover
and in humans has shown great potential as an index of
nutritional status and growth rate [27,28]. The CHIK
patients showed higher excreted levels of hydroxyproline
than proline indicates increased collagen turnover (Table
2). On follow-up study in the selected CHIK patients,
increased levels of mucopolysacchariedes, proline and
hydroxyproline indicates highermetabolic turnover in
early days and recedes progressively in later days (Table
3).
Conclusion
In CHIK patients the collagen and connective tissue
metabolism was greatly affected and increased metabo-
lism leads to increased excretion of proline, hydroxypro-
line and mucopolysaccharides in urine compared to
healthy controls. It indicates that the CHIK virus infec-
tion, connective tissue typically exhibits inflammatory
response and leads to the damage of cartilage and connec-
tive tissue; increases metabolism and releases degraded




During last year July – October 2006, CHIK out break in
Andhra Pradesh, India, a total of 75 (45 males + 30
females) patients were selected based on disease symp-
toms for this study. We also taken the 20 age-matched
healthy persons were chosen from the community and
used as control subjects. Blood and urine samples were
collected from each subject with their prior written con-
sent for further studies. From all subjects, 5 ml of blood
was collected in heparinized tubes and centrifuged at
1500 ×g for 15 min at 4 C. Plasma and pelleted RBC were
separated stored in eppendorf tubes and kept at -80 C
Table 3: Changes of urinary proline, hydroxyproline and mucopolysaccharides during week long Chikungunya fever.
Day Proline mg/l Hydroxyproline mg/l Mucopolysaccharides mg/l
Day 1 32 ± 2.1 263 ± 22 380 ± 45
Day 2 30 ± 1.6 251 ± 43 372 ± 30
Day 3 25 ± 2.0 228 ± 38 354 ± 26
Day 4 20 ± 1.8 210 ± 24 325 ± 28
Day 5 16 ± 2.0 186 ± 15 300 ± 30
Day 6 15 ± 1.5 160 ± 13 260 ± 22
Day 7 10 ± 0.8 138 ± 11 221 ± 18
Day 8 10 ± 0.5 130 ± 10 210 ± 16
Day 9 9 ± 0.8 120 ± 14 185 ± 10
Day 10 7 ± 0.54 100 ± 10 160 ± 12Virology Journal 2008, 5:31 http://www.virologyj.com/content/5/1/31
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until analysis. Commercially available kits measured
Blood analysis and other general parameters.
Urine analysis
The urine samples were collected from the patients and
used for estimation of mucopolysaccharides, proline and
hydroxyproline. Total urinary hydroxyproline determina-
tions were performed employing the method described by
Cleary and Saunders (1974) [29]. Briefly, urine was
passed through a column of ion retardation resin to
remove acid, salts, and pigments. From the column eluate,
urine hydroxyproline determination was performed by
oxidized to pyrrole 2-carboxylic acid and then to pyrole.
The color produced with dimethyl amino-benzaldehyde
is masured at 560 nm [30]. The proline levels in urine
sample were measured by the method of Bates et al
(1973) [31]. Two ml urine sample mixed with 2 ml acid
ninhydrin reagent and kept in boiling water bath for 1 h.
The tubes transferred to an ice bath to terminate the reac-
tion. 5 ml toluene was added and mixed and read at 520
nm against the toluene blank. Screening test for mucopol-
ysaccharides in urine was tested by Cetyl Trimethyl
Ammonium Bromide (CTAB) test. Five ml of fresh urine
was added to 1 ml of CTAB (cetavilon) solution (50 g/l in
citrate buffer (1 M) of pH 6.0). A heavy precipitate indi-
cated the presence of mucopolysaccharides (Varley et al
1990). The DMB assay was performed essentially for
measurement of mucopolysaccharides according to the
method of Whitley et al. (1989) [32]. Briefly, the DMB
(1,9-dimethylmethylene blue) dye solution was prepared
by dissolving 16 mg of DMB, 3.04 g of glycine, 2.37 g of
sodium chloride, and 0.5 mL of 0.1 mol/l hydrochloric
acid in 1 l of distilled water. The pH of the solution was
adjusted to 3. For each assay, the patient's urine specimen
was mixed with 1 ml of the dye solution at room temper-
ature, and measured absorbance at 525 nm without delay
after mixing the sample and dye solution. The assay was
calibrated verses a standard curve of chondroitin sulfate
(5–100 mg/l). The results were expressed as mg/l. All
colorimetric estimations of above biochemical parame-
ters in samples were measured by using BIOTEK ELISA
Reader.
Statistical analysis
Statistical analysis was performed by GraphPad InStat
software. Subjects with CHIK were compared with healthy
controls. Means and standard error of means were calcu-
lated and differences between means were student's t-test.
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